Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Lyme arthritis: A small piece of the larger autoimmunity puzzle Rob Volansky
• ACR applauds telehealth flexibility, coding changes to proposed 2022 Physician Fee Schedule Jason Laday
• Janssen seeks FDA approval of ustekinumab for juvenile psoriatic arthritis Lisa Holden
• Outpatient COVID-19 management: Do your immunosuppressed patients know who to call? Leonard H. Calabrese, DO
• FDA approves avacopan for ANCA-associated vasculitis Jason Laday
• FDA approves Cyltezo as first interchangeable biosimilar for inflammatory disease Jason Laday
• 'Cascade of Impact': COVID-19 surge again threatens patient access to maintenance drugs Rob Volansky
• Hooked on Rheum with Ellen M. Gravallese, MD Rob Volansky
• COVID-19 lockdown linked to higher flare rate in patients with JIA Jason Laday
• COVID-19 testing 20% higher among patients with immune-mediated inflammatory disease Jason Laday
• Dermatomyositis incidence, prevalence higher than previously reported Jason Laday
• Live varicella-zoster vaccine effective, 'can be safely used' with TNF inhibitors Jason Laday
• mRNA COVID-19 vaccines 87% effective at preventing hospitalization amid delta surge Jason Laday
• Mycophenolate mofetil plus glucocorticoids boosts response in immune thrombocytopenia Jason Laday
• Oligoarticular PsA occurs in 47% of patients, presents similarly to polyarticular disease Jason Laday
• Olokizumab improves signs, symptoms, physical function in methotrexate-refractory RA Jason Laday
• Patients with psoriatic arthritis prioritize work, 'normal activities' over clinical efficacy Jason Laday
• Race not a 'substantial' predictor of functional outcomes after total knee replacement Jason Laday
• Statin use does not significantly increase rheumatoid arthritis risk Jason Laday
• US patients with Behçet's disease mostly female, with more biologic use vs. endemic areas Jason Laday
• Conflicting guidelines highlight controversies in osteoporosis management Rob Volansky
• Fibromyalgia diagnosis may be confounded by small fiber neuropathy Rob Volansky
• JAK inhibitors tied to increased CV, cancer risk in RA: 'But is it clinically meaningful?' Rob Volansky
• Concerns linger for ‘problematic’ 2021 ACR RA guidelines Rob Volansky
• Sharing treatment target goals, 'mutual conversation' with patients key to PsA outcomes Rob Volansky
• 'Tips and tricks' for improving diagnosis, treatment of musculoskeletal disease Rob Volansky
• Battling COVID-19 vaccine misinformation: What are you telling your patients? Jason Laday